Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus

FEMS Immunology and Medical Microbiology

Volumn 29, Issue 2, 2000, Pages 145-153

  Lorenz, Udo ^a   Ohlsen, Knut ^a   Karch, Helge ^b   Hecker, Michael ^c   Thiede, Arnulf ^a   Hacker, Jörg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Antibody response; Antigen; Immunoblot; Sepsis; Staphylococcus aureus

Indexed keywords

ANTIBODY; ANTIGEN; PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNODOMINANT EPITOPES; METHICILLIN RESISTANCE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PHOSPHOENOLPYRUVATE SUGAR PHOSPHOTRANSFERASE SYSTEM; SEPSIS; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPPORT, NON-U.S. GOV'T;

EID: 0033829979     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00199-1     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention (1996) National Nosocomial Infection Surveillance System report: data summary from October 1986-April 1996. U.S. Department of Health and Human Services, Atlanta, GA.
2. Romero-Vivas J., Rubio M., Fernandez C., Picazo J.J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 21:1995;1417-1423.
3. Witte W., Klare I. Antibiotic resistance in bacterial pathogens: microbiological and epidemiological aspects. Bundesgesund.bl. Gesundh.forsch. Gesundh.schutz. 42:1999;8-16.
4. Panlilio A.L., Culver D.H., Gaynes R.P., Banerjee S., Henderson T.S., Tolson J.S., Martone W.J. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect. Control. Hosp. Epidemiol. 13:1992;582-586.
5. Sieradzki K., Tomasz A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J. Bacteriol. 181:1999;7566-7570.
6. Smith T.L., Pearson M.L., Wilcox K.R., Cruz C., Lancaster M.V., Robinson-Dunn B., Tenover F.C., Zervos M.J., Band J.D., White E., Jarvis W.R. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. New Engl. J. Med. 340:1999;493-501.
7. Hauer T., Lacour M., Gastmeier P., Schulgen G., Schumacher M., Ruden H., Daschner F. Nosocomial infections intensive care units. A nation-wide prevalence study. Anaesthesist. 45:1996;1184-1191.
8. Fattom A.I., Sarwar J., Ortiz A., Naso R.A. Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect. Immun. 64:1996;1659-1665.
9. Karakawa W.W., Sutton A., Schneerson R., Karpas A., Vann W.F. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect. Immun. 56:1988;1090-1095.
10. Lee J.C., Park J.S., Shepherd S.E., Carey V., Fattom A. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect. Immun. 65:1997;4146-4151.
11. Scott D.F., Best G.K., Kling J.M., Thompson M.R., Adinolfi L.E., Bonventre P.F. Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1. Rev. Infect. Dis. 11:(Suppl 1):1989;214-218.
12. Thakker M., Park J.S., Carey V., Lee J.C. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytotic and enhances bacterial virulence in a murine bacteremia model. Infect. Immun. 66:1998;5183-5189.
13. Christensson B., Espersen F., Hedstrom S.A., Kronvall G. Methodological aspects of Staphylococcus aureus peptidoglycan serology: comparisons between solid-phase radioimmunoassay and enzyme-linked immunosorbent assay. J. Clin. Microbiol. 19:1984;680-686.
14. Tyski S., Colque-Navarro P., Hryniewicz W., Granstrom M., Mollby R. Lipase versus teichoic acid and alpha-toxin as antigen in an enzyme immunoassay for serological diagnosis of Staphylococcus aureus infections. Eur. J. Clin. Microbiol. Infect. Dis. 10:1991;447-449.
15. Verbrugh H.A., Nelson R.D., Peterson P.K., Wilkinson B.J., Thompson R.L. Serology of Staphylococcus aureus infections using multiple antigens and serial serum samples. J. Infect. Dis. 148:1983;608.
16. Wergeland H.I., Haaheim L.R., Natas O.B., Wesenberg F., Oeding P. Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. J. Clin. Microbiol. 27:1989;1286-1291.
17. Greenberg D.P.A., Bayer S., Turner D., Ward J.I. Antibody responses to protein A in patients with Staphylococcus aureus bacteremia and endocarditis. J. Clin. Microbiol. 28:1990;458-462.
18. Schmitz F.J., MacKenzie C.R., Geisel R., Wagner S., Idel H., Verhoef J., Hadding U., Heinz H.P. Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur. J. Epidemiol. 13:1997;699-708.
19. Verbrugh H.A., Peters R., Goessens W.H., Michel M.F. Distinguishing complicated from uncomplicated bacteremia caused by Staphylococcus aureus: the value of 'new' and 'old' serological tests. J. Infect. Dis. 153:1986;109-115.
20. McKenney D., Pouliot K.L., Wang Y., Murthy V., Ulrich M., Doring G., Lee L.C., Goldmann D.A., Pier G.B. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 284:1999;1523-1527.
21. Foster T.J., Höök M. Surface proteins adhesins of Staphylococcus aureus. Trends Microbiol. 6:1998;484-488.
22. Balaban N., Goldkorn T., Nhan R.T., Dang L.B., Scott S., Ridgley R.M., Rasooly A., Wright S.C., Larrick J.W., Rasooly R., Carlson J.R. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science. 280:1998;438-440.
23. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 101:1992;1644-1655.
24. Pospiech A., Neumann B. A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet. 11:1995;217-218.
25. Ziebuhr W., Heilmann C., Gotz F., Meyer P., Wilms K., Straube E., Hacker J. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect. Immun. 65:1997;890-896.
26. Laemmli U.K. Cleavage of structural polypeptides during assembly of the head of bacteriophage T4. Nature. 277:1970;680-685.
27. Ohlsen K., Koller K.P., Hacker J. Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla:lacZ gene fusion. Infect. Immun. 65:1997;3606-3614.
28. Wessel D., Flugge U.I. A method for the quantitative recovery of polypeptide in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138:1984;141-143.
29. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of polypeptides in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
30. Institute for Genomic Research Jan 10, 2000, posting date (Online) Preliminary sequence data were obtained from The Institute for Genomic Research website at http://www.tigr.org (Aug 13, 1999, last update).
31. Cuny C., Witte W. Typing of Staphylococcus aureus by PCR for DNA sequences flanked by transposon Tn916 target region and ribosomal binding site. J. Clin. Microbiol. 34:1996;1502-1505.
32. Bell J.A., Pennington T.H., Petrie D.T. Western blot analysis of staphylococcal antibodies present in human sera during health and disease. J. Med. Microbiol. 23:1987;95-99.
33. Krikler S.J., Lambert P.A. Extracellular proteins as a potential marker of active Staphylococcus aureus infection in bone. J. Med. Microbiol. 37:1992;227-231.
34. Bradley S.F., Terpenning M.S., Ramsey M.A., Zarins L.T., Jorgensen K.A., Sottile W.S., Schaberg D.R., Kauffman C.A. Methicillin resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann. Intern. Med. 115:1991;417-422.
35. Coello R., Jimenez J., Garcia M., Arroyo P., Minguez D., Fernandez C., Cruzet F., Gaspar C. Prospective study of infection, colonization and carriage of methicillin resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur. J. Clin. Microbiol. Infect. Dis. 13:1994;74-81.
36. Muder R.R., Brennen C., Wagener M.M., Vickers R.M., Rihs J.D., Hancock G.A., Yee Y.C., Miller J.M., Yu V.L. Methicillin resistant staphylococcal colonization and infection in a long-term care facility. Ann. Intern. Med. 114:1991;107-112.
37. Schiotz P.O., Hoiby N., Hertz J.B. Cross-reactions between Staphylococcus aureus and fifteen other bacterial species. Acta Pathol. Microbiol. Scand. (B). 87:1979;329-336.
38. Traub W.H., Bauer D., Leonhard B. Immunobiology of methicillin resistant Staphylococcus aureus: immune response of rabbits and patients to systemic infection. Chemotherapy. 42:1996;118-132.
39. Beyreuther K., Raufuss H., Schrecker O., Hengstenberg W. The phosphoenolpyruvate-dependent phosphotransferase system of Staphylococcus aureus. 1. Amino-acid sequence of the phosphocarrier protein HPr. Eur. J. Biochem. 75:1977;275-286.
40. Kalbitzer H.R., Hengstenberg W. The solution structure of the histidine-containing protein (HPr) from Staphylococcus aureus as determined by two-dimensional 1H-NMR spectroscopy. Eur. J. Biochem. 216:1993;205-214.
41. Kalbitzer H.R., Neidig K.P., Hengstenberg W. Two-dimensional 1H NMR studies on HPr protein from Staphylococcus aureus: complete sequential assignments and secondary structure. Biochemistry. 30:1991;11186-11192.
42. Qoronfleh M.W., Weraarchakul W., Wilkinson B.J. Antibodies to a range of Staphylococcus aureus and Escherichia coli heat shock proteins in sera from patients with S. aureus endocarditis. Infect. Immun. 61:1993;1567-1570.
43. Sheagren J.N. Guidelines for the use of the teichoic acid antibody assay. Arch. Intern. Med. 144:1984;250-252.
44. Wheat L.J., Wilkinson B.J., Kohler R.B., White A.C. Antibody response to peptidoglycan during staphylococcal infections. J. Infect. Dis. 147:1983;16-22.
45. Wistow G. Cold shock and DNA binding. Nature. 344:1990;823-824.
46. Dubreuil J.D., Jacques M., Brochu D., Frenette M., Vadeboncoeur C. Surface location of HPr, a phosphocarrier of the phosphoenolpyruvate: sugar phosphotransferase system in Streptococcus suis. Microbiology. 142:1996;837-843.